Active immune response protects Stat6VT transgenic mice from developing a lymphoproliferative disorder

Area of Science:

• Immunology
• Molecular Biology
• Cell Biology

Background:

• Signal Transducer and Activator of Transcription 6 (Stat6) is a key transcription factor mediating Interleukin-4 (IL-4) and Interleukin-13 (IL-13) signaling.
• Stat6 is implicated in regulating cellular proliferation, differentiation, and survival, with emerging evidence linking it to lymphoproliferative disorders (LPD).

Purpose of the Study:

• To investigate the role of a constitutively active form of Stat6 (Stat6VT) in T lymphocytes in the development of LPD.
• To explore the impact of environmental factors and antigen exposure on Stat6-mediated LPD.

Main Methods:

• Generation of mice expressing a constitutively active Stat6 (Stat6VT) primarily in T lymphocytes.
• Housing Stat6VT mice in standard (non-pathogen-free) environments and assessing LPD incidence.
• Analysis of Stat6-regulated gene expression in lymphocytes from Stat6VT/LPD mice.
• Evaluating the effect of antigen exposure via immunization on LPD development in Stat6VT mice.

Main Results:

• Stat6VT mice housed in a non-pathogen-free environment exhibited a significantly increased incidence (37%) of LPD compared to those in pathogen-free conditions (approximately 5%).
• Examination of lymphocytes from Stat6VT/LPD mice revealed no common genetic alterations in Stat6-regulated genes associated with tumorigenesis.
• Complete abrogation of LPD in Stat6VT mice was observed following uniform antigen exposure through immunization.

Conclusions:

• Environmental factors, potentially including microbial exposure, can influence the incidence of Stat6-mediated lymphoproliferative disorders.
• Antigen exposure appears to play a critical role in preventing the development of LPD in Stat6VT mice, suggesting a complex interplay between Stat6 signaling, the immune environment, and lymphoproliferation.